{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:21:23Z","timestamp":1773418883409,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3203,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.ki.5002141","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T10:41:22Z","timestamp":1172140882000},"page":"374-376","source":"Crossref","is-referenced-by-count":15,"title":["Aldosterone antagonists: Silver bullet or just sodium excretion and potassium retention?"],"prefix":"10.1016","volume":"71","author":[{"given":"U.","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002141_bb0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.ki.5002075","article-title":"Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis","volume":"71","author":"Kramer","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002141_bb0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/hrt.2003.025312","article-title":"Aldosterone blockade in cardiovascular disease","volume":"90","author":"Struthers","year":"2004","journal-title":"Heart"},{"key":"10.1038\/sj.ki.5002141_bb0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2215\/CJN.00120106","article-title":"Aldosterone antagonism in chronic kidney disease","volume":"1","author":"Pondo","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002141_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pcad.2006.02.002","article-title":"Use of aldosterone antagonists in resistant hypertension","volume":"48","author":"Calhoun","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1038\/sj.ki.5002141_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5002141_bb0035","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5002141_bb0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"Chrysostomou","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002141_bb0045","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002141_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.1956","article-title":"ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats","volume":"209","author":"Hamming","year":"2006","journal-title":"J Pathol"},{"key":"10.1038\/sj.ki.5002141_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ki.5000079","article-title":"Receptor-mediated actions of renin and prorenin","volume":"69","author":"Oliver","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002141_bb0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002141_bb0065","first-page":"24","article-title":"Syllabus fluid, electrolytes, and acid-base disturbances","volume":"5","author":"Sterns","year":"2006","journal-title":"NephSAP"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815523971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815523971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T10:37:21Z","timestamp":1626863841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815523971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0085253815523971"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002141","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}